Environmental pollutants and breast cancer.
293
TL;DR: Substantial work is needed in exposure assessment, toxicology, and susceptibility before the authors can expect a pay-off from large epidemiologic studies of breast cancer and environment, and few hypothesis-generating toxicologic studies limit the scope of epidemiological studies.
read more
Abstract: Breast cancer is the most common cancer in women and the leading cause of cancer death among women 35-54 years of age. Rising incidence, increased risk among migrants to higher risk regions, and poor prediction of individual risk have prompted a search for additional modifiable factors. Risk factors for breast cancer include reproductive characteristics associated with estrogen and other hormones, pharmaceutical hormones, and activities such as alcohol use and lack of exercise that affect hormone levels. As a result, investigation of hormonally active compounds in commercial products and pollution is a priority. Compounds that cause mammary tumors in animals are additional priorities. Animal models provide insight into possible mechanisms for effects of environmental pollutants on breast cancer and identify chemical exposures to target in epidemiologic studies. Although few epidemiologic studies have been conducted for chemical exposures, occupational studies show associations between breast cancer and exposure to certain organic solvents and polycyclic aromatic hydrocarbons (PAHs). Population-based studies have been limited to a few organochlorine compounds and PAHs and have been mostly negative. A variety of challenges in studies of breast cancer and the environment may have contributed to negative findings. Lack of exposure assessment tools and few hypothesis-generating toxicologic studies limit the scope of epidemiologic studies. Issues of timing with respect to latency and periods of breast vulnerability, and individual differences in susceptibility pose other challenges. Substantial work is needed in exposure assessment, toxicology, and susceptibility before we can expect a pay-off from large epidemiologic studies of breast cancer and environment.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Embodied health movements: new approaches to social movements in health.
Phil Brown,Stephen Zavestoski,Sabrina McCormick,Brian Mayer,Rachel Morello-Frosch,Rebecca Gasior Altman +5 more
TL;DR: Various elements of social movement theory are employed to offer an approach to understanding embodied health movements, and a capsule example of one such movement is provided, the environmental breast cancer movement.
601
A review of the carcinogenic potential of bisphenol A.
Darcie D. Seachrist,Kristen L. Weber Bonk,Shuk-Mei Ho,Gail S. Prins,Ana M. Soto,Ruth A. Keri +5 more
TL;DR: There is substantial evidence from rodent studies indicating that early-life BPA exposures below the RfD lead to increased susceptibility to mammary and prostate cancer.
448
Pesticides in the urban environment: A potential threat that knocks at the door
Islam Md Meftaul,Kadiyala Venkateswarlu,Rajarathnam Dharmarajan,Prasath Annamalai,Mallavarapu Megharaj +4 more
TL;DR: The present critical review is the first single source that provides updated knowledge on the sources, nature and extent of pesticide pollution in the urban environment, and the ecological and human health effects of pesticides and their residues.
351
Global status of DDT and its alternatives for use in vector control to prevent disease.
TL;DR: Support is needed for integrated and multipartner strategies of vector control and for the continued development of new technologies as sustainable alternatives to reliance on DDT.
346
Endocrine disrupting chemicals in the atmosphere: Their effects on humans and wildlife
TL;DR: The review explores the literature that addresses the major occurring EDCs in the atmosphere including phthalates, polychlorinated biphenyls (PCBs), polycyclic aromatic hydrocarbons (PAHs), brominated flame retardants (BFRs), dioxins, alkylphenols (APs) and perfluorinated chemicals (PFCs).
289
References
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
Jacques E. Rossouw,Garnet L. Anderson,Ross L. Prentice,Andrea Z. LaCroix,Charles Kooperberg,Marcia L. Stefanick,Rebecca D. Jackson,Shirley A.A. Beresford,Barbara V. Howard,Karen C. Johnson,Jane Morley Kotchen,Judith K. Ockene +11 more
TL;DR: Overall health risks exceeded benefits from use of combined estrogen plus progestin for an average 5.2-year follow-up among healthy postmenopausal US women, and the results indicate that this regimen should not be initiated or continued for primary prevention of CHD.
•Book
The Merck index: An encyclopedia of chemicals, drugs, and biologicals
Martha Windholz
- 01 Jan 1983
TL;DR: The Merck Index as discussed by the authors is a one-volume encyclopedia of chemicals, drugs and biologicals that contains more than 10,000 monographs, each monograph is a concise description of a single substance or a small group of closely related compounds.
5K
Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually
Mitchell H. Gail,Louise A. Brinton,David P. Byar,Donald K. Corle,Sylvan B. Green,Catherine Schairer,John J. Mulvihill +6 more
TL;DR: To assist in medical counseling, a method to estimate the chance that a woman with given age and risk factors will develop breast cancer over a specified interval is presented and individualized breast cancer probabilities are calculated.
3.4K
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer
Eugenia E. Calle,Clark W. Heath,R. J. Coates,Jonathan M. Liff,Silvia Franceschi,R. Talamini,N. Chantarakul,Suporn Koetsawang,D. Rachawat,A. Morabia,L. Schuman,Walter F. Stewart,Moyses Szklo,Chris Bain,F. Schofield,Victor Siskind,Philip A. Band,Andrew J. Coldman,Richard P. Gallagher,T. G. Hislop,P. Yang,Stephen W. Duffy,L. M. Kolonel,A. M.Y. Nomura,Mark W. Oberle,Howard W. Ory,Herbert B. Peterson,Hoyt G. Wilson,Phyllis A. Wingo,K. Ebeling,D. Kunde,P. Nishan,Graham A. Colditz,Nicholas G. Martin,Tieng Pardthaisong,S. Silpisornkosol,C. Theetranont,B. Boosiri,S. Chutivongse,P. Jimakorn,Pramuan Virutamasen,C. Wongsrichanalai,Anthony J. McMichael,T. Rohan,Marianne Ewertz,Carle Paul,David C. G. Skegg,G. F. S. Spears,P. Boyle,M. Evstifeeva,J. R. Daling,W. B. Hutchinson,Kathi Malone,E. A. Noonan,Janet L. Stanford,David B. Thomas,N. S. Weiss,Emily White,N. Andrieu,A. Bràmond,F Clavel,B. Gairard,J. Lansac,L. Piana,R. Renaud,S. R.P. Fine,H. R. Cuevas,P. Ontiveros,A. Palet,S. B. Salazar,N. Aristizabel,A. Cuadros,A. Bachelot,M. G. Lê,J. Deacon,Julian Peto,C. N. Taylor,E. Alfandary,Baruch Modan,Elaine Ron,Gary D. Friedman,Robert A. Hiatt,T. Bishop,J. Kosmelj,M. Primic-Zakelj,B. Ravnihar,J. Stare,W. L. Beeson,Graeme Fraser,R. D. Bulbrook,Jack Cuzick,I. S. Fentiman,J. L. Hayward,De Yun Wang,R. L. Hanson,M. C. Leske,Martin C. Mahoney,P. C. Nasca,A. O. Varma,A. L. Weinstein,Torgil Möller,Håkan Olsson,Jonas Ranstam,R.A. Goldbohm,P.A. van den Brandt,R. A. Apelo,J. Baens,J. R. de la Cruz,B. Javier,L. B. Lacaya,Corazon A. Ngelangel,C. La Vecchia,E. Negri,Ettore Marubini,Monica Ferraroni,Mariette Gerber,Sylvia Richardson,C. Segala,D. Gatei,P. Kenya,A. Kungu,J. G. Mati,L A Brinton,Robert N. Hoover,Catherine Schairer,Robert Spirtas,H. P. Lee,Matti A. Rookus,F.E. van Leeuwen,J. A. Schoenberg,Marilie D. Gammon,E. A. Clarke,Lee W. Jones,Klim McPherson,A. Neil,M. Vessey,D. Yeates,Valerie Beral,Diana Bull,B. Crossley,C Hermon,Simon Jones,Timothy J. Key,Claire E. Lewis,Gillian K Reeves,Rory Collins,Richard Doll,Richard Peto,P. Hannaford,Kay Cr,Luis Rosero-Bixby,Jian-Min Yuan,H. Y. Wei,T. Yun,C. Zhiheng,G. Berry,J Cooper Booth,T. Jelihovsky,Robert MacLennan,R. Shearman,Q. S. Wang,C. J. Baines,Anthony B. Miller,C. Wall,Eiliv Lund,H. Stalsberg,A. Dabancens,L. Martinez,R. Molina,O. Salas,Freda E. Alexander,B. S. Hulka,C. E. D. Chilvers,Leslie Bernstein,Robert W. Haile,Annlia Paganini-Hill,M. C. Pike,R. K. Ross,Giske Ursin,Mimi C. Yu,M. P. Longnecker,Polly A. Newcomb,T. M.N. Farley,S. Holck,O. Meirik,Hans-Olov Adami,R. Bergkvist,Ingemar Persson,Fabio Levi,Kiyohiko Mabuchi,Dale L. Preston,Klea Katsouyanni,Antonia Trichopoulou,D. Trichopoulos,Leif Bergkvist +194 more
TL;DR: Of the many factors examined that might affect the relation between breast cancer risk and use of HRT, only a woman's weight and body-mass index had a material effect: the increase in the relative risk of breast cancer diagnosed in women using HRT and associated with long durations of use in current and recent users was greater for women of lower than of higher weight or body- mass index.
2.5K
Cancer burden in the year 2000. The global picture.
TL;DR: Three elementary measures of cancer frequency are confined ourselves to: incidence, mortality and prevalence.
2.3K
Related Papers (5)
[...]
Marilie D. Gammon,Mary S. Wolff,Alfred I. Neugut,Sybil M. Eng,Susan L. Teitelbaum,Julie A. Britton,Mary Beth Terry,Bruce Levin,Steven D. Stellman,Steven D. Stellman,Geoffrey C. Kabat,Maureen Hatch,Ruby T. Senie,Gertrud S. Berkowitz,H. Leon Bradlow,Gail C. Garbowski,Carla Maffeo,Pat Montalvan,Margaret Kemeny,Marc L. Citron,Freya Schnabel,Allan Schuss,Steven I. Hajdu,Vincent Vinceguerra,Nancy J. Niguidula,Nancy J. Niguidula,Karen Ireland,Regina M. Santella +27 more